"The Columbia Center for Liver Disease and Transplantation (CLDT) offers adults and children with liver disease seamless of medical, surgical and radiologic expertise in one location. Our hepatology experts offer extensive experience diagnosing and treating all forms and stages of liver disease, including antiviral treatment for Hepatitis C and Hepatitis B and liver transplantation. We can assess and treat liver disease with medical and surgical options. CLDT is also a primary transplantation center. We offer novel treatments for patients with liver cancer and cancers of the bile duct, or cancer that started elsewhere in the body and has spread to the liver."

During the past decade, Columbia University Medical Center - Center for Liver Disease and Transplantation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center - Center for Liver Disease and Transplantation" are "Cirrhosis" (1 trials), "Decompensated Cirrhosis" (1 trials), "Hepatic Encephalopathy" (1 trials) and "Primary Biliary Cirrhosis" (1 trials). Many other conditions were trialed in "Columbia University Medical Center - Center for Liver Disease and Transplantation" in a lesser frequency.

Most popular intervention types in "Columbia University Medical Center - Center for Liver Disease and Transplantation" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Elafibranor 80mg" (1 trials), "Emricasan (25 mg)" (1 trials), "Emricasan (5 mg)" (1 trials) and "HPN-100" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Medical Center - Center for Liver Disease and Transplantation" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University Medical Center - Center for Liver Disease and Transplantation". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Columbia University Medical Center - Center for Liver Disease and Transplantation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Medical Center - Center for Liver Disease and Transplantation, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".